Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/02/063170
CTRI/2024/02/063170
Not yet recruiting
Phase 2

Evaluation of efficacy and safety of Polyherbal Unani formulations Itrifal Shahtara orally and Marham Quba topically in the management of Quba (Tinea Corporis) - NI

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: L00-L08- Infections of the skin and subcutaneous tissueHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L00-L08- Infections of the skin and subcutaneous tissueHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue
Sponsor
Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital

Eligibility Criteria

Inclusion Criteria

  • •1\.Clinically diagnosed and potassium hydroxide mount (KOH) confirmed cases of dermatophytosis.
  • •2\.Patients who agree to sign the written consent form and follow the protocol.

Exclusion Criteria

  • •1\.Pregnant and lactating women.
  • •2\.Patients exclusively affecting the scalp, palms, and soles.
  • •3\.Patients suffering from concomitant diseases like psoriasis and eczema.
  • •4Patients suffering from severe systemic and metabolic diseases like diabetes mellitus, hepatorenal dysfunctions etc.
  • •5\.Patients having treatment history of less than 7days in case of topical antifungal medication and 30 days in case of oral antifungal agents and systemic corticosteroids.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Evaluation of efficacy and safety of Polyherbal Unani formulations in the management of Eczema
CTRI/2024/02/062979Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush
Not yet recruiting
Phase 2
To Asses efficacy and safety of polyherbal unani formulation In Nazla
CTRI/2023/10/058727State Unani Medical College Himmatganj Prayagraj
Recruiting
Phase 2
Clinical Study to Evaluate the Effect of Polyherbal Unani formulations in Waram-e-lawzatayn Muzmin (Chronic Tonsillitis).
CTRI/2023/09/057524Ministry of Ayush UP
Recruiting
Phase 2
Clinical Study To Evaluate the efficacy of polyherbal Unani formulation in Zukam (Coryza OR Common Cold)
CTRI/2023/08/056975State Unani Medical College
Completed
Phase 2
Clinical Trial of Polyherbal Formulation COVI-RB01 As An Add-On Therapy With Standard of Care In Mild And Moderate Covid-19 Positive PatientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2021/10/037378Alakart Bio Pharma Pvt Ltd130